Ye F - Search Results

1

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.

Sosman JA, Kim KB, Schuchter L, Gonzalez R, Pavlick AC, Weber JS, McArthur GA, Hutson TE, Moschos SJ, Flaherty KT, Hersey P, Kefford R, Lawrence D, Puzanov I, Lewis KD, Amaravadi RK, Chmielowski B, Lawrence HJ, Shyr Y, Ye F, Li J, Nolop KB, Lee RJ, Joe AK, Ribas A. Sosman JA, et al. Among authors: ye f. N Engl J Med. 2012 Feb 23;366(8):707-14. doi: 10.1056/NEJMoa1112302. N Engl J Med. 2012. PMID: 22356324 Free PMC article. Clinical Trial.

2

The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels.

Osusky KL, Hallahan DE, Fu A, Ye F, Shyr Y, Geng L. Osusky KL, et al. Among authors: ye f. Angiogenesis. 2004;7(3):225-33. doi: 10.1007/s10456-004-3149-y. Angiogenesis. 2004. PMID: 15609077

3

Balanced two-stage designs for phase II clinical trials.

Ye F, Shyr Y. Ye F, et al. Clin Trials. 2007;4(5):514-24. doi: 10.1177/1740774507084102. Clin Trials. 2007. PMID: 17942467 Clinical Trial.

4

Shortage of chemotherapeutic agents in Iraq and outcome of childhood acute lymphocytic leukemia, 1990-2002.

Frangoul H, Al-Jadiry MF, Shyr Y, Ye F, Shakhtour B, Al-Hadad SA. Frangoul H, et al. Among authors: ye f. N Engl J Med. 2008 Jul 24;359(4):435-7. doi: 10.1056/NEJMc0803444. N Engl J Med. 2008. PMID: 18650525 No abstract available.

5

Implementing a computerized pneumococcal vaccination reminder system in an emergency department: a prospective study.

Dexheimer JW, Talbot TR, Ye F, Shyr Y, Jones I, Gregg WM, Aronsky D. Dexheimer JW, et al. Among authors: ye f. AMIA Annu Symp Proc. 2008 Nov 6:867. AMIA Annu Symp Proc. 2008. PMID: 18999135 Clinical Trial.

6

A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer.

Mutter R, Lu B, Carbone DP, Csiki I, Moretti L, Johnson DH, Morrow JD, Sandler AB, Shyr Y, Ye F, Choy H. Mutter R, et al. Among authors: ye f. Clin Cancer Res. 2009 Mar 15;15(6):2158-65. doi: 10.1158/1078-0432.CCR-08-0629. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276291 Clinical Trial.

7

Ischemia/reperfusion unveils impaired capacity of older adults to restrain oxidative insult.

Davies SS, Traustadóttir T, Stock AA, Ye F, Shyr Y, Harman SM, Roberts LJ 2nd. Davies SS, et al. Among authors: ye f. Free Radic Biol Med. 2009 Oct 1;47(7):1014-8. doi: 10.1016/j.freeradbiomed.2009.07.005. Epub 2009 Jul 21. Free Radic Biol Med. 2009. PMID: 19596063 Free PMC article.

8

Functional genomic screens identify CINP as a genome maintenance protein.

Lovejoy CA, Xu X, Bansbach CE, Glick GG, Zhao R, Ye F, Sirbu BM, Titus LC, Shyr Y, Cortez D. Lovejoy CA, et al. Among authors: ye f. Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19304-9. doi: 10.1073/pnas.0909345106. Epub 2009 Nov 4. Proc Natl Acad Sci U S A. 2009. PMID: 19889979 Free PMC article.

9

Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model.

Kobayashi H, Huang J, Ye F, Shyr Y, Blackwell TS, Lin PC. Kobayashi H, et al. Among authors: ye f. PLoS One. 2010 Mar 5;5(3):e9458. doi: 10.1371/journal.pone.0009458. PLoS One. 2010. PMID: 20221440 Free PMC article.

10

RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells.

Bauer JA, Ye F, Marshall CB, Lehmann BD, Pendleton CS, Shyr Y, Arteaga CL, Pietenpol JA. Bauer JA, et al. Among authors: ye f. Breast Cancer Res. 2010;12(3):R41. doi: 10.1186/bcr2595. Epub 2010 Jun 24. Breast Cancer Res. 2010. PMID: 20576088 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,230 results

Search Page